Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high- Dose cytarabine chemotherapy without stem-cell transplantation

Journal of Clinical Oncology

Volumn 31, Issue 22, 2013, Pages

  Aoki, Tomohiro ^a   Harada, Yasuhiko ^a   Matsubara, Erina ^a   Morishita, Takanobu ^a   Suzuki, Tatsuya ^a   Kasai, Masanobu ^a   Uchida, Toshiki ^a   Tsuzuki, Toyonori ^a   Nakamura, Shigeo ^b   Ogura, Michinori ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; BLEOMYCIN; CD15 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD5 ANTIGEN; CD79A ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EOSIN; ETOPOSIDE; HEMATOXYLIN; LATENT MEMBRANE PROTEIN 1; PREDNISOLONE; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; CLASSICAL HODGKIN LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; COUGHING; DRUG MEGADOSE; EOSINOPHIL; EPSTEIN BARR VIRUS; FEMALE; HEALTH CARE QUALITY; HISTIOCYTE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL LYMPHOMA; LONG TERM CARE; LUNG BIOPSY; LUNG LESION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; NEUTROPHIL; PATHOGENESIS; PERICARDITIS; PLASMA CELL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STEM CELL TRANSPLANTATION; STOMACH LESION; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; LUNG TUMOR; PATHOLOGY; RECURRENT DISEASE;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHOMATOID GRANULOMATOSIS; RECURRENCE;

EID: 84884771863     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.47.4999     Document Type: Article

References (27)

1. Coiffier B, Lepage E, Briere J, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235-242, 2002
2. Pfreundschuh M, Kuhnt E, Trümper L, et al: CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12:1013-1022, 2011
3. Pfreundschuh M, Trümper L, Osterborg A, et al: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: A randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379-391, 2006
4. Katzenstein AL, Carrington CB, Liebow AA: Lymphomatoid granulomatosis: A clinicopathologic study of 152 cases. Cancer 43:360-373, 1979
5. Asano N, Yamamoto K, Tamaru J, et al: Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: Comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood 113:2629-2636, 2009
6. Jordan K, Grothey A, Grothe W, et al: Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol 74:263-266, 2005
7. Wilson WH, Kingma DW, Raffeld M, et al: Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood 87:4531-4537, 1996
8. Hu YH, Liu CY, Chiu CH, et al: Successful treatment of elderly advanced lymphomatoid granulomatosis with rituximab-CVP combination therapy. Eur J Haematol 78:176-177, 2007
9. Jung KH, Sung HJ, Lee JH, et al: A case of pulmonary lymphomatoid granulomatosis successfully treated by combination chemotherapy with rituximab. Chemotherapy 55:386-390, 2009
10. Oosting-Lenstra SF, van Marwijk Kooy M: Failure of CHOP with rituximab for lymphomatoid granulomatosis. Neth J Med 65:442-447, 2007
11. Pisani RJ, DeRemee RA: Clinical implications of the histopathologic diagnosis of pulmonary lymphomatoid granulomatosis. Mayo Clin Proc 65:151-163, 1990
12. Rao R, Vugman G, Leslie WT, et al: Lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol 1:658-660; discussion 660, 2003
13. Robak T, Kordek R, Urbanska-Rys H, et al: High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement. Leuk Lymphoma 47:1667-1669, 2006
14. Lemieux J, Bernier V, Martel N, et al: Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis. Hematology 7:355-358, 2002
15. Ogura M, Kagami Y, Taji H, et al: Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma. Int J Hematol 77:503-511, 2003
16. Oki Y, Ogura M, Kato H, et al: Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer Sci 99:179-184, 2008
17. Baldi A, Groeger AM, Esposito V, et al: Lymphomatoid granulomatosis of the lung: A clinico-pathological study. Anticancer Res 18:4621-4624, 1998
18. Bernstein ML, Reece ER, de Chadarévian JP, et al: Bone marrow transplantation in lymphomatoid granulomatosis: Report of a case. Cancer 58:969-972, 1986
19. Fauci AS, Haynes BF, Costa J, et al: Lymphomatoid granulomatosis: Prospective clinical and therapeutic experience over 10 years. N Engl J Med 306:68-74, 1982
20. Makol A, Kosuri K, Tamkus D, et al: Lymphomatoid granulomatosis masquerading as interstitial pneumonia in a 66-year-old man: A case report and review of literature. J Hematol Oncol 2:39, 2009
21. Johnston A, Coyle L, Nevell D: Prolonged remission of refractory lymphomatoid granulomatosis after autologous hemopoietic stem cell transplantation with post-transplantation maintenance interferon. Leuk Lymphoma 47:323-328, 2006
22. Dunleavy K, Chattopadhyay P, Kawada J, et al: Immune characteristics associated with lymphomatoid granulomatosis and outcome following treatment with interferon-alpha. Presented at the 53rd ASH Annual Meeting and Exposition, San Diego, CA, December 10-13, 2010 (abstr 963)
23. Katzenstein AL, Peiper SC: Detection of Epstein-Barr virus genomes in lymphomatoid granulomatosis: Analysis of 29 cases by the polymerase chain reaction technique. Mod Pathol 3:435-441, 1990
24. Nicholson AG, Wotherspoon AC, Diss TC, et al: Lymphomatoid granulomatosis: Evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma. Histopathology 29:317-324, 1996 24a. Roschewski M, Wilson WH: Lymphomatoid granulomatosis. Cancer J 18:469-474, 2012
25. Polizzotto MN, Dawson MA, Opat SS: Failure of rituximab monotherapy in lymphomatoid granulomatosis. Eur J Haematol 75:172-173, 2005
26. Hiraga J, Tomita A, Sugimoto T, et al: Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: Its prevalence and clinical significance. Blood 113:4885-4893, 2009
27. Oyama T, Yamamoto K, Asano N, et al: Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients. Clin Cancer Res 13:5124-5132, 2007